Vantris

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2016
02420082016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
PURPOSE We aimed at evaluating the efficacy and complications of two bulking substances: dextranomer/hyaluronic acid copolymer(Dx… (More)
Is this relevant?
Review
2016
Review
2016
BACKGROUND Endoscopic correction of vesicoureteral reflux (VUR) in children offers minimally invasive management and is widely… (More)
  • table 1
Is this relevant?
2014
2014
OBJECTIVE Our aim was to evaluate the efficacy and safety of single endoscopic injection of Vantris in young girls affected by… (More)
Is this relevant?
2014
2014
We aimed to evaluate prospectively the efficacy of Vantris as a new non-biodegradable tissue-augmenting substance in children… (More)
  • table 1
  • table 2
Is this relevant?
Review
2014
Review
2014
OBJECTIVE To evaluate an outcome of endoscopic correction of vesicoureteral reflux (VUR) using Vantris (Promedon, Cordoba… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2014
2014
We aimed to compare the success rates of the double hydrodistention implantation technique (HIT) and the HIT with a polyacrylate… (More)
  • table 1
Is this relevant?
2013
2013
OBJECTIVE To evaluate the efficacy of Vantris in children with vesicoureteral reflux (VUR) after 3 years of prospective follow-up… (More)
  • table 1
  • table 2
Is this relevant?
2013
2013
From June 1991 to December 2011, endoscopic treatment of vesicoureteral reflux (VUR) was performed more than in 4,000 children… (More)
Is this relevant?
2011
2011
PURPOSE The aim of this study was to evaluate the efficacy of single injection of a new non-biodegradable agent (Vantris… (More)
  • table 1
  • table 2
Is this relevant?
2008
2008
Biodegradable injectable bulking agents of animal origin present a fast rate of bio-reabsorption and may cause an allergic… (More)
Is this relevant?